549 related articles for article (PubMed ID: 28273820)
1. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of LCB01-0062, a novel oxazolidinone.
Jung SJ; Yun IN; Park HS; Lee HH; Jeong JW; Kim YZ; Cho YL; Kwak JH
Int J Antimicrob Agents; 2012 Dec; 40(6):539-43. PubMed ID: 23058227
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus.
Oh SH; Park HS; Lee JH; Baek SY; Chae SE; Oh K; Cho YL; Kwak JH
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186032
[No Abstract] [Full Text] [Related]
4. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.
Barman TK; Kumar M; Mathur T; Chaira T; Ramkumar G; Kalia V; Rao M; Pandya M; Yadav AS; Das B; Upadhyay DJ; Hamidullah ; Konwar R; Raj VS; Singh H
Antimicrob Agents Chemother; 2016 Dec; 60(12):7134-7145. PubMed ID: 27645240
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of a series of alpha-substituted acetylpiperazinyl oxazolidinones.
Wang XJ; Du GJ; Zhao SQ; Yan M; Gu LQ
Chem Biol Drug Des; 2009 Sep; 74(3):276-81. PubMed ID: 19703029
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.
Jeong JW; Jung SJ; Lee HH; Kim YZ; Park TK; Cho YL; Chae SE; Baek SY; Woo SH; Lee HS; Kwak JH
Antimicrob Agents Chemother; 2010 Dec; 54(12):5359-62. PubMed ID: 20855730
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of 5-substituted oxazolidinones.
Phillips OA; Udo EE; Ali AA; Al-Hassawi N
Bioorg Med Chem; 2003 Jan; 11(1):35-41. PubMed ID: 12467705
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activities of N-substituted-glycinyl 1H-1,2,3-triazolyl oxazolidinones.
Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
Eur J Med Chem; 2013 Aug; 66():246-57. PubMed ID: 23811087
[TBL] [Abstract][Full Text] [Related]
10. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
[TBL] [Abstract][Full Text] [Related]
11. Oxazolidinone-containing Hybrids with Antibacterial Activity against Methicillin-resistant Staphylococcus aureus (MRSA): A Mini-review.
Jiang D; Liu B; Gao T
Curr Top Med Chem; 2021; 21(27):2440-2454. PubMed ID: 33185161
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria.
Liu J; He B; Yu A; Zhou W
Chem Biol Drug Des; 2007 Apr; 69(4):265-8. PubMed ID: 17461974
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
Candel FJ; Morales G; Picazo JJ
Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of linezolid and other antibiotics against Gram-positive bacteria from the major teaching hospitals in Kuwait.
Al Sweih N; Mokaddas E; Jamal W; Phillips OA; Rotimi VO
J Chemother; 2005 Dec; 17(6):607-13. PubMed ID: 16433190
[TBL] [Abstract][Full Text] [Related]
15. Novel oxazolidinone-quinolone hybrid antimicrobials.
Gordeev MF; Hackbarth C; Barbachyn MR; Banitt LS; Gage JR; Luehr GW; Gomez M; Trias J; Morin SE; Zurenko GE; Parker CN; Evans JM; White RJ; Patel DV
Bioorg Med Chem Lett; 2003 Dec; 13(23):4213-6. PubMed ID: 14623004
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
[TBL] [Abstract][Full Text] [Related]
17. An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.
Kaushik A; Heuer AM; Bell DT; Culhane JC; Ebner DC; Parrish N; Ippoliti JT; Lamichhane G
Bioorg Med Chem Lett; 2016 Aug; 26(15):3572-6. PubMed ID: 27329794
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).
Zhao C; Sun H; Wang H; Liu Y; Hu B; Yu Y; Sun Z; Chu Y; Cao B; Liao K; Lei J; Hu Z; Zhang L; Zhang X; Xu Y; Wang Z; Chen M
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):174-81. PubMed ID: 22521693
[TBL] [Abstract][Full Text] [Related]
19. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials.
Johnson PD; Aristoff PA; Zurenko GE; Schaadt RD; Yagi BH; Ford CW; Hamel JC; Stapert D; Moerman JK
Bioorg Med Chem Lett; 2003 Dec; 13(23):4197-200. PubMed ID: 14623000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
